Related Experiment Video
Updated: Jan 5, 2026
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Prediction of Hypoxia in Brain Tumors Using a Multivariate Model Built from MR Imaging and 18F-Fluorodeoxyglucose
Yukie Shimizu1, Kohsuke Kudo2,3, Hiroyuki Kameda2
1Department of Radiation Medicine, Hokkaido University Graduate School of Medicine.
Purpose:
The aim of this study was to generate a multivariate model using various MRI markers of blood flow and vascular permeability and accumulation of 18F-fluorodeoxyglucose (FDG) to predict the extent of hypoxia in an 18F-fluoromisonidazole (FMISO)-positive region.
Methods:
Fifteen patients aged 27-74 years with brain tumors (glioma, n = 13; lymphoma, n = 1; germinoma, n = 1) were included. MRI scans were performed using a 3T scanner, and dynamic contrast-enhanced (DCE) perfusion and arterial spin labeling images were obtained. Ktrans and Vp maps were generated using the DCE images. FDG and FMISO positron emission tomography scans were also obtained. A model for predicting FMISO positivity was generated on a voxel-by-voxel basis by a multivariate logistic regression model using all the MRI parameters with and without FDG. Receiver-operating characteristic curve analysis was used to detect FMISO positivity with multivariate and univariate analysis of each parameter. Cross-validation was performed using the leave-one-out method.
Results:
The area under the curve (AUC) was highest for the multivariate prediction model with FDG (0.892) followed by the multivariate model without FDG and univariate analysis with FDG and Ktrans (0.844 for all). In cross-validation, the multivariate model with FDG had the highest AUC (0.857 ± 0.08) followed by the multivariate model without FDG (0.834 ± 0.119).
Conclusion:
A multivariate prediction model created using blood flow, vascular permeability, and glycometabolism parameters can predict the extent of hypoxia in FMISO-positive areas in patients with brain tumors.
Insights
This study developed a predictive model using MRI and FDG scans to assess brain tumor hypoxia. The model accurately predicts the extent of hypoxia in 18F-fluoromisonidazole (FMISO)-positive regions, aiding treatment planning.
Area of Science:
- Neuroradiology
- Oncology
- Medical Imaging
Background:
- Hypoxia is a critical factor influencing brain tumor response to therapy.
- Accurate assessment of tumor hypoxia is essential for effective treatment strategies.
Purpose of the Study:
- To develop a multivariate model predicting hypoxia extent in 18F-fluoromisonidazole (FMISO)-positive regions.
- To integrate MRI markers of blood flow, vascular permeability, and 18F-fluorodeoxyglucose (FDG) uptake for hypoxia prediction.
Main Methods:
- Fifteen brain tumor patients underwent 3T MRI (DCE perfusion, ASL), 18F-fluorodeoxyglucose (FDG) PET, and 18F-fluoromisonidazole (FMISO) PET.
- Multivariate logistic regression models were built using MRI parameters (Ktrans, Vp) with and without FDG to predict FMISO positivity.
- Receiver-operating characteristic (ROC) curve analysis and leave-one-out cross-validation were employed.
Main Results:
- The multivariate prediction model incorporating FDG achieved the highest area under the curve (AUC) of 0.892.
- Cross-validation confirmed the superior performance of the FDG-enhanced model (AUC = 0.857 ± 0.08).
- Models without FDG and univariate analysis with Ktrans showed comparable, though lower, predictive values.
Conclusions:
- A multivariate model integrating MRI-derived blood flow, vascular permeability, and glycometabolism (FDG uptake) effectively predicts hypoxia extent in FMISO-positive brain tumor areas.
- This approach offers a non-invasive method for assessing tumor hypoxia, potentially guiding treatment decisions.
